iSpecimen Inc.
ISPCNasdaqIndustrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $9.3M | $9.9M | $10.4M | $11.1M | $8.2M |
| Operating income | −$9.0M | −$12.7M | −$11.2M | −$10.2M | −$5.9M | −$2.4M |
| Net income | −$10.5M | −$12.5M | −$11.1M | −$10.2M | −$9.0M | −$4.7M |
| Total assets | $9.5M | $9.4M | $15.8M | $24.6M | $35.7M | $6.2M |
| Total liabilities | $6.4M | $6.0M | $6.1M | $4.3M | $5.9M | $22.3M |
| Equity | $3.1M | $3.3M | $9.7M | $20.3M | $29.8M | −$27.3M |
| EPS (diluted) | $-2.28 | $-17.58 | $-1.23 | $-1.16 | $-2.09 | $-4.97 |
| Shares out. | 2.5M | 9.1M | 9.0M | 8.8M | 8.7M | 936,213 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −465.4%
- Net margin
- −543.7%
- Return on equity
- −339.6%
- Return on assets
- −110.0%
- Return on capital (ROCE)
- −272.0%
- Liabilities / assets
- 67.6%
- Debt / equity
- 2.09×
- Book value / share
- $1.24
- Revenue growth (YoY)
- −79.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -33.49distress
- Accruals / assets
- −65.5%clean
- Beneish M-Score
- 10.04elevated
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2025
- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Kmissed a reporting deadline ↗Mar 26, 2025
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Obf Investments, LlcPassive (13G)Feb 14, 2025
- Wolf James G.Passive (13G)Jul 9, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 112,840 | 1.0 | +119.2% |
| Apr 30, 2026 | 51,489 | 1.0 | -99.1% |
| Apr 15, 2026 | 5.5M | 1.0 | +852.0% |
| Mar 31, 2026 | 580,752 | 1.0 | -81.1% |
| Mar 13, 2026 | 3.1M | 1.0 | +227.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJun 1, 2026
- Shareholder voteMay 29, 2026
- Entered a material agreement · Delisting / listing-standard notice · Unregistered equity sale · Regulation FD disclosure · Other material eventMay 13, 2026
- Amended charter or bylaws · Other material eventMay 1, 2026
- Other material eventApr 13, 2026
- Regulation FD disclosureApr 10, 2026
- Other material eventMar 13, 2026
- Director / officer changeFeb 23, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTJun 1, 2026
- 8-KCURRENT REPORTMay 29, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 18, 2026
- 10-QQUARTERLY REPORTMay 18, 2026
- NT 10-QNOTIFICATION OF LATE FILINGMay 18, 2026
- DMay 14, 2026
- 8-KCURRENT REPORTMay 13, 2026
- 8-KCURRENT REPORTMay 1, 2026
- 8-KCURRENT REPORTApr 13, 2026
- 8-KCURRENT REPORTApr 10, 2026
- 10-KANNUAL REPORTApr 1, 2026
- NT 10-KNOTIFICATION OF LATE FILINGMar 31, 2026
- 8-KCURRENT REPORTMar 13, 2026
- DEFA14ADEFINITIVE ADDITIONAL MATERIALSMar 3, 2026
- 8-KCURRENT REPORTFeb 23, 2026